Interventions for Tuberculosis Control and Elimination 2002

96. Asai S, Shimoda T, Hara K, Fujiwara K. Occupational asthma caused by isonicontinic
acid hydrazide (INH) inhalation. J Allerg Clin Immunol 1987; 80: 578-82.
97. Polosa R, Colombrita R, Prosperini G, Cacciola R. A case of acute deterioration
in asthma symptoms induced by isoniazid prophylaxis.
91: 438-40.
Respir Med 1997;
98. Bomb BS, Purohit SD, Bedi HK. Stevens-Johnson syndrome caused by isoniazid.
Tubercle 1976; 57: 229-30.
99. Yamasaki R, Yamasaki M, Kawasaki Y, Nagasako R. Generalized pustular dermatosis
caused by isoniazid. Br J Dermatol 1985; 112: 504-6.
100. Holdiness MR.
1986; 15: 282-8.
Contact dermatitis to antituberculosis drugs. Contact Dermatitis
101. Kopanoff DE, Snider DE, Caras GJ.
Dis 1978; 117: 991-1001.
Isoniazid-related hepatitis. Am Rev Respir
102. Gal AA, Klatt EC. Fatal isoniazid hepatitis in a child. (Correspondence). Pediatr
Infect Dis 1986; 5: 490-1.
103. Murphy R, Swartz R, Watkins PB. Severe actetominophen toxicity in a patient
receiving isoniazid. (Correspondence). Ann Intern Med 1990; 113: 799-800.
104. Moulding TS, Redeker AG, Kanel GC. Acetominophen, isoniazid, and hepatic
toxicity. Ann Intern Med 1991; 114: 431.
105. Stephenson I, Qualie M, Wiselka MJ. Hepatic failure and encephalopathy attributed
to an interaction between acetaminophen and rifampicin.
Am J Gastroenterol 2001; 96: 1310-1.
(Correspondence).
106. Tuberculosis Chemotherapy Centre Madras. The prevention and treatment of isoniazid
toxicity in the therapy of pulmonary tuberculosis. 1. An assessment of
two vitamin B preparations and glutamic acid.
28: 455-75.
Bull World Health Organ 1963;
107. Tuberculosis Chemotherapy Centre Madras. The prevention and treatment of isoniazid
toxicity in the therapy of pulmonary tuberculosis. 2. An assessment of
the prophylactic effect of pyridoxine in low dosage.
1963; 29: 457-81.
Bull World Health Organ
108. McCune R, Deuschle K, McDermott W. The delayed appearance of isoniazid
antagonism by pyridoxine in vivo. Am Rev Tuberc Pulm Dis 1957; 76: 1100-5.
109. O’Brien RJ, Long MW, Cross FS, Lyle MA, Snider DE, Jr. Hepatotoxicity from
isoniazid and rifampin among children treated for tuberculosis.
72: 491-9.
Pediatrics 1983;
110. Riska N. Hepatitis cases in isoniazid treated groups and in a control group. Bull
Int Union Tuberc 1976; 51: 203-8.
111. Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis
for adult tuberculin reactors. (Editorial). Am Rev Respir Dis 1975; 111: 573-7.
177